Phenotype
|
Fish
|
Conditions
|
Figures
|
diencephalon development disrupted, abnormal
|
Df(Chr07)t4/t4 + MO3-zic2a
|
standard conditions
|
Fig. 5
from Sanek et al., 2008
|
diencephalon development disrupted, abnormal
|
AB + MO3-zic2a
|
chemical treatment: ethanol
|
Fig. 6
from Sanek et al., 2008
|
ventral thalamus decreased size, abnormal
|
AB + MO3-zic2a
|
chemical treatment: ethanol
|
Fig. 6
from Sanek et al., 2008
|
cell proliferation in forebrain disrupted, abnormal
|
AB + MO3-zic2a
|
chemical treatment: 5-bromo-2'-deoxyuridine
|
Fig. 4
from Sanek et al., 2008
|
diencephalon development disrupted, abnormal
|
AB + MO3-zic2a
|
chemical treatment: ethanol, chemical treatment: Cyclopamine
|
Fig. 6
from Sanek et al., 2008
|
ventral thalamus decreased size, abnormal
|
AB + MO3-zic2a
|
chemical treatment: ethanol, chemical treatment: Cyclopamine
|
Fig. 6
from Sanek et al., 2008
|
optic fissure closure incomplete, abnormal
|
AB + MO3-zic2a
|
standard conditions
|
Fig. 6
from Sanek et al., 2009
|
diencephalon development disrupted, abnormal
|
AB + MO3-zic2a
|
standard conditions
|
Fig. 1 ,
Fig. 2 ,
Fig. 5
from Sanek et al., 2008
|
ventral thalamus decreased size, abnormal
|
AB + MO3-zic2a
|
standard conditions
|
Fig. 1 ,
Fig. 2 ,
Fig. S3 ,
Fig. S4
from Sanek et al., 2008
|
negative regulation of DNA-templated transcription disrupted, abnormal
|
AB + MO3-zic2a
|
standard conditions
|
Fig. 2 ,
Fig. 3
from Sanek et al., 2009
|
neurogenesis disrupted, abnormal
|
AB + MO3-zic2a
|
standard conditions
|
Fig. 3
from Sanek et al., 2008
|
regulation of smoothened signaling pathway disrupted, abnormal
|
AB + MO3-zic2a
|
standard conditions
|
Fig. 3
from Sanek et al., 2009
|
neural crest cell migration decreased process quality, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 5
from Teslaa et al., 2013
|
trunk has fewer parts of type xanthoblast, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 6
from Teslaa et al., 2013
|
head has fewer parts of type xanthoblast, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 6
from Teslaa et al., 2013
|
pharyngeal arch 1 decreased size, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 7
from Teslaa et al., 2013
|
hypothalamus cellular quality, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 8
from Teslaa et al., 2013
|
fourth ventricle malformed, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
text only
from Nyholm et al., 2007
|
tectal ventricle malformed, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
text only
from Nyholm et al., 2007
|
neurocranial trabecula shortened, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 3
from Teslaa et al., 2013
|
midbrain malformed, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 7
from Nyholm et al., 2007
|
ventral mandibular arch malformed, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 1
from Teslaa et al., 2013
|
forebrain development decreased process quality, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 8
from Teslaa et al., 2013
|
pharyngeal arch 2 malformed, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 1
from Teslaa et al., 2013
|
pharyngeal arch 2 decreased size, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 7
from Teslaa et al., 2013
|
retinal neural layer decreased size, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
text only
from Nyholm et al., 2007
|
cranial neural crest mislocalised dorsally, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 5
from Teslaa et al., 2013
|
hindbrain malformed, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 7
from Nyholm et al., 2007
|
optic fissure malformed, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
text only
from Nyholm et al., 2007
|
ethmoid cartilage medial region absent, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 3
from Teslaa et al., 2013
|
embryonic neurocranium morphogenesis decreased process quality, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 3
from Teslaa et al., 2013
|
pharyngeal arch cellular quality, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 3
from Teslaa et al., 2013
|
xanthophore differentiation decreased process quality, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 6
from Teslaa et al., 2013
|
neural tube malformed, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
text only
from Nyholm et al., 2007
|
pharyngeal arch cartilage hypoplastic, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 1
from Teslaa et al., 2013
|
ventral thalamus cellular quality, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 8
from Teslaa et al., 2013
|
stomodeum decreased size, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 8
from Teslaa et al., 2013
|
embryonic viscerocranium morphogenesis decreased process quality, abnormal
|
WT + MO3-zic2a
|
standard conditions
|
Fig. 1 ,
Fig. 3 ,
Fig. 7
from Teslaa et al., 2013
|
negative regulation of DNA-templated transcription disrupted, abnormal
|
smob641/b641 + MO3-zic2a
|
standard conditions
|
Fig. 3
from Sanek et al., 2009
|
diencephalon development disrupted, abnormal
|
smob641/b641 + MO3-zic2a
|
standard conditions
|
Fig. 5
from Sanek et al., 2008
|
regulation of smoothened signaling pathway disrupted, abnormal
|
smob641/b641 + MO3-zic2a
|
standard conditions
|
Fig. 3
from Sanek et al., 2009
|
alar plate midbrain region apical junction complex patchy, abnormal
|
WT + MO1-zic5 + MO3-zic2a
|
standard conditions
|
Fig. 4
from Nyholm et al., 2009
|
midbrain malformed, abnormal
|
WT + MO1-zic5 + MO3-zic2a
|
standard conditions
|
Fig. 2,
Fig. 6
from Nyholm et al., 2009
Fig. 7 ,
Fig. 8
from Nyholm et al., 2007
|
cell proliferation in midbrain disrupted, abnormal
|
WT + MO1-zic5 + MO3-zic2a
|
standard conditions
|
Fig. 9
from Nyholm et al., 2007
|
actin-myosin filament sliding decreased rate, abnormal
|
WT + MO1-zic5 + MO3-zic2a
|
standard conditions
|
Fig. 3
from Nyholm et al., 2009
|
secondary neural tube formation process quality, abnormal
|
WT + MO1-zic5 + MO3-zic2a
|
standard conditions
|
Fig. 2
from Nyholm et al., 2009
|
tectal ventricle malformed, abnormal
|
WT + MO1-zic5 + MO3-zic2a
|
standard conditions
|
Fig. 2
from Nyholm et al., 2009
Fig. 7 ,
Fig. 8
from Nyholm et al., 2007
|
tectal ventricle decreased size, abnormal
|
WT + MO1-zic5 + MO3-zic2a
|
standard conditions
|
Fig. 2
from Nyholm et al., 2009
|
hindbrain malformed, abnormal
|
WT + MO1-zic5 + MO3-zic2a
|
standard conditions
|
Fig. 7 ,
Fig. 8
from Nyholm et al., 2007
|
regulation of mitotic cell cycle, embryonic process quality, abnormal
|
WT + MO1-zic5 + MO3-zic2a
|
standard conditions
|
Fig. 6
from Nyholm et al., 2009
|
alar plate midbrain region physical object quality, abnormal
|
WT + MO1-zic5 + MO3-zic2a
|
standard conditions
|
Fig. 3
from Nyholm et al., 2009
|
midbrain development process quality, abnormal
|
WT + MO1-zic5 + MO3-zic2a
|
standard conditions
|
Fig. 2,
Fig. 6
from Nyholm et al., 2009
|
ventral thalamus cellular quality, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 8
from Teslaa et al., 2013
|
xanthophore differentiation decreased process quality, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 6
from Teslaa et al., 2013
|
melanoblast mislocalised, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 6
from Teslaa et al., 2013
|
neural crest cell differentiation decreased process quality, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 4
from Teslaa et al., 2013
|
pharyngeal arch 1 decreased size, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 7
from Teslaa et al., 2013
|
melanocyte migration decreased process quality, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 6
from Teslaa et al., 2013
|
neural crest cell cellular quality, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 4
from Teslaa et al., 2013
|
pharyngeal arch 2 decreased size, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 7
from Teslaa et al., 2013
|
neural crest cell migration decreased process quality, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 5
from Teslaa et al., 2013
|
melanoblast aggregated, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 6
from Teslaa et al., 2013
|
head has fewer parts of type melanoblast, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 6
from Teslaa et al., 2013
|
forebrain development decreased process quality, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 8
from Teslaa et al., 2013
|
melanocyte differentiation decreased process quality, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 6
from Teslaa et al., 2013
|
embryonic viscerocranium morphogenesis decreased process quality, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 7
from Teslaa et al., 2013
|
pharyngeal arch 3 decreased size, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 7
from Teslaa et al., 2013
|
cranial neural crest mislocalised dorsally, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 5
from Teslaa et al., 2013
|
head has fewer parts of type xanthoblast, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 6
from Teslaa et al., 2013
|
pharyngeal arch 4 decreased size, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 7
from Teslaa et al., 2013
|
trunk has fewer parts of type melanoblast, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 6
from Teslaa et al., 2013
|
hypothalamus cellular quality, abnormal
|
WT + MO2-zic2b + MO3-zic2a
|
standard conditions
|
Fig. 8
from Teslaa et al., 2013
|
rhombomere 3 decreased size, abnormal
|
WT + MO2-zic2b + MO2-zic3 + MO3-zic2a
|
standard conditions
|
Fig. 6
from Drummond et al., 2013
|
rhombomere 5 decreased size, abnormal
|
WT + MO2-zic2b + MO2-zic3 + MO3-zic2a
|
standard conditions
|
Fig. 6
from Drummond et al., 2013
|
motor nucleus of vagal nerve anatomical region decreased size, abnormal
|
rw0Tg + MO2-zic2b + MO3-zic2a + MO4-tp53
|
standard conditions
|
Fig. 10
from Drummond et al., 2013
|
retinoic acid receptor signaling pathway decreased process quality, abnormal
|
sk71Tg + MO2-zic2b + MO3-zic2a + MO4-tp53
|
standard conditions
|
Fig. 8
from Drummond et al., 2013
|